Kilitch Drugs (India) has informed that the meeting of the Board of Directors of the Company is scheduled on 31/08/2018, to consider and approve the conversion of 16,00,000 Warrants issued at a price of Rs 59 per warrant and allotment of 16,00,000 Equity shares of face value of Rs 10 each pursuant to such conversion of Warrants. Further, pursuant to applicable provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in securities of the Company shall remain closed from August 28, 2018 to August 31, 2018 for the Directors, Officers and all the designated Employees of the Company for prevention of insider trading.
The above information is a part of company’s filings submitted to BSE.
